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Abstract
Microvascular integrity is lost during cerebral ischemia. Detachment of the microvascular basement
membrane (BM) from the astrocyte, as well as degradation of the BM, is responsible for the loss of
microvascular integrity. However, their ultrastructural and temporal changes during cerebral
ischemia are not well known. Male Sprague-Dawley rats were subjected to permanent middle
cerebral artery occlusion (MCAO) for 1, 4, 8, 12, 16, 20, and 48 hr. By using transmission electron
microscopy, the proportion of intact BM–astrocyte contacts and electron densities of the BM were
measured from five randomly selected microvessels in the ischemic basal ganglia. Their temporal
changes and associations with activities of the matrix metalloproteinases (MMPs) were investigated.
The intact portion of the BM–astrocyte contacts was decreased significantly within 4 hr and was
rarely observed at 48 hr after MCAO. Decreases in the electron density and degradation of the BM
were significant 12 hr after MCAO. The intact BM–astrocyte contacts and the mean BM density
showed a significant positive correlation (r = 0.784, P < 0.001). MMP-9 activity was correlated
negatively with the intact BM–astrocyte contacts (r = −0.711, P < 0.001) and with the BM density
(r = −0.538, P 5 0.0016). The increase in MMP-9 coincided temporally with the loss of the BM–
astrocyte contacts and a decrease in the BM density. Ultrastructural alterations occurring in the
microvascular BM and its contacts with astrocyte endfeet were temporally associated in cerebral
ischemia. Time courses of their alterations should be considered in the treatment targeted to the
microvascular BM and its contact with astrocytes.
Keywords
cerebral ischemia; astrocytes; basement membrane; electron microscopy
Brain edema and hemorrhagic transformation are major consequences of cerebral ischemic
injury. Brain edema is the leading cause of death during the first week after cerebral infarction
(Vahedi et al., 2007), and hemorrhagic transformation is a major obstacle of thrombolytic
treatment, diminishing its efficacy. Both pathologic conditions are associated with damage to
the cerebral microvessels. In addition, microvascular damage may contribute to cell death
(Heo et al., 1999). In this regard, protection of the microvessels from ischemic injury could be
a major target for specific treatments in acute stroke patients.
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The cerebral microvessels are a constituent of the blood–brain barrier (BBB), which is
composed of microvascular endothelial cells, the basement membrane (BM), astrocyte endfeet,
and pericytes (Ballabh et al., 2004). The BM attaches endothelial cells to one side and astrocyte
endfeet to the other side. The astrocyte endfeet form an envelope around the blood vessels and
are attached to the BM tightly by their adhesion molecules. The BM is composed of
extracellular matrix (ECM) molecules such as type IV collagen, laminins, fibronectin, heparan
sulfates, and proteoglycans. The integrity of the microvessels is maintained by the presence of
an intact BM that provides structural support to the endothelial cell wall and astrocytes. The
intact BM is also critical in delivering communicative signals between the intravascular
components and the glial/neuronal cells and in providing cellular nutritional support from the
blood (Iadecola, 2004; Jan et al., 2004; del Zoppo and Milner, 2006).
Loss of microvascular integrity induced by cerebral ischemia has been demonstrated in
pioneering studies in nonhuman primates, which showed a decrease in the ECM molecules and
integrins that attach the BM to the endothelium and astrocyte endfeet in the ischemic area
(Hamann et al., 1995; Wagner et al., 1997). Over the last decade, several studies have shown
that degradation of the microvascular BM is mediated by the uncontrolled activity of proteases
(Rosenberg et al., 1996; Heo et al., 1999; Chang et al., 2003; Fukuda et al., 2004). Among the
proteases, matrix metalloproteinases (MMPs), particularly MMP-9 and MMP-2, are key
enzymes in degrading the ECM components of the BM, and their increases are known to be
associated with brain edema, hemorrhagic transformation, and ischemic injury after cerebral
ischemia (Rosenberg et al., 1998; Heo et al., 1999, 2003, 2005; Rosell et al., 2006; Zhao et al.,
2007).
Molecular pathways involved in the degradation of the microvascular BM may be suitable
targets for the specific treatment of brain edema, hemorrhagic transformation, and possibly
anoikis-type cell death in stroke patients. These treatments should be initiated before the
damage is serious or irreversible. However, temporal patterns of microvascular damage such
as detachment of the BM–astrocyte contact and degradation of the BM are not well known. In
this study, the temporal changes in the cerebral microvascular BM and surrounding astrocyte
contacts and the density of the BM were examined with transmission electron microscopy
(TEM) in rats subjected to permanent middle cerebral artery occlusion (MCAO). Additionally,
their temporal relationships with MMP activities were investigated.
MATERIALS AND METHODS
Experimental Animals and Preparation
Male Sprague-Dawley (SD) rats weighing 250–320 g were used. The care and use of laboratory
animals in this experiment were performed according to the institutionally approved protocol
in accordance with the National Institutes of Health’s Guide for the care and use of laboratory
animals. For operative procedures, the animals were anesthetized with an inhalation of 5%
isofluorane in a mixture of 70% N2O and 30% O2. Anesthesia was maintained with 2%
isofluorane. During the operative procedures, body temperature was monitored continuously
with a rectal probe and was maintained at 37.0°C ± 0.5°C by means of a homeothermic blanket
control unit and heating pad (Harvard Apparatus, Holliston, MA). The left femoral artery was
cannulated with PE-50 tubing for the monitoring of arterial blood pressure with a pressure
transducer (Harvard Apparatus) and for the analysis of arterial pH, PaO2, PaCO2, and
hemoglobin concentration before and after MCAO (OPTI critical care analyze; AVL Scientific
Corporation, Roswell, GA). Regional cerebral blood flow (rCBF) was determined in the
territory of the MCA (1 mm caudal to the bregma and 3 mm lateral to the midline) by laser-
Doppler flowmetry (LDF; BLF 21 laser Doppler flowmeter; Transonic Systems Inc., Ithaca,
NY).
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Induction of Acute Focal Cerebral Ischemia and Experimental Groups
The rats were subjected to permanent MCAO, as described previously (Choi et al., 2007), for
1, 4, 8, 12, 16, 20, and 48 hr (five in each group). Four rats were used for controls and underwent
the sham operation, which was performed in the same manner as MCAO, except that the MCA
was not occluded.
Motor Disability Test
Neurologic evaluation was performed before and after MCAO and before sacrifice. All
surviving animals were graded on a known scale (Garcia et al., 1995). Briefly, six items were
evaluated. Zero to three points were given to each item when an animal had a deficit and
summed for a total score. The minimum neurologic score is 3 and the maximum is 18. The
items evaluated were 1) ability to approach all four walls of the cage, 2) symmetry in the
movement of four limbs, 3) forepaw outstretching, 4) climbing and gripping abilities on the
wire cage, 5) reaction to stimulus on both sides of body, and 6) response to vibrissae touch.
Brain Tissue Preparation
All animals were sacrificed by transcardiac perfusion with cold heparinized normal saline using
a peristaltic pump under deep anesthesia with an intraperitoneal urethane injection. The
removed brains were sectioned into 2-mm-thick coronal blocks using a rat brain matrix. The
fourth coronal blocks from the frontal pole were prefixed with a Karnovsky solution (2%
glutaraldehyde, 2% paraformaldehyde, 0.5% CaCl2) and used for TEM.
The third blocks of the brain were divided into ischemic and nonischemic hemispheres. The
divided blocks were embedded into cryomolds with Tissue-Tek OCT compound (Miles Inc.,
Elkahart, IN) and quick-frozen with 2-methylbutan, cooled with dry ice, and then stored at
−80°C. These frozen blocks were used for gelatin zymography.
Extraction of Protein and Purification of MMPs
The 50 cryostat 10 µm-thick frozen sections were homogenized with 400 µl of working buffer
(50 mM Tris HCl, pH 7.5, 150 ml NaCl, 5 mM CaCl2, 0.05% BRIJ-35, 0.02% NaN3, 1% Triton
X-100) containing 1 mM phenylmethylsulfonyl fluoride and centrifuged at 4°C and 9,000 rpm
for 20 min. MMPs were purified based on a method using gelatin-sepharose 4B (Choi et al.,
2007). Briefly, after rinsing 50 µl of gelatin-sepharose 4B (Pharmacia Biotech, Uppsala,
Sweden) with 200 µl of working buffer three times, the protein extracts were mixed and
incubated on a rocking plate for 30 min at 4°C. Then, the samples were centrifuged at 7,000
rpm for 5 min, rinsed with 200 µl working buffer, and centrifuged again. The precipitates were
added to 50 µl of elution buffer (working buffer to which 10% dimethylsulfoxide had been
added) and incubated for 30 min, while rocking at 4°C. After centrifugation, the supernatant
was taken and stored at −80°C until needed for gelatin zymography.
Gelatin Zymography
The purified protein extracts were mixed with an equal volume of sample buffer [80 mM Tris-
HCl, pH 6.8, 4% sodium dodecyl sulfate (SDS), 10% glycerol, 0.01% bromophenol blue] and
were subjected to zymography as previously published (Heo et al., 1999; Choi et al., 2007).
The gelatinolytic activity of these samples was detected by 8% SDS-polyacrylamide gel
containing 1% gelatin. Sample gels were rinsed in 150 ml of 2.5% Triton X-100 (15 min) and
incubated with 250 ml of 50 mmol/liter Tris-HCl buffer (pH 7.5, 10 mM CaCl2, 0.02%
NaN3) for 43 hr at 37°C. After incubation, the gels were stained with 0.1% amido black
containing acetic acid, methanol, and distilled water (volume ratio 1:3:6) for 1 hr and then
destained by four washes with the same solution without amido black for 130 min. These gels
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were scanned using a flatbed scanner, and the gelatinolytic bands were analyzed and quantified
by means of a gel plotting macro using the Scion Image program.
Transmission Electron Microscopy
For electron microscopic observations, the fourth blocks of the brain were fixed with
glutaraldehyde in 2% paraformaldehyde overnight at 4°C, washed in 0.1 M phosphate buffer,
pH 7.4, and then postfixed in 1% osmium tetroxide in the same buffer for 15 min. Then, the
specimens were dehydrated through a graded series of ethanol, exchanged through propylene
oxide, and embedded in a mixture of Epon. Subsequently, ultrathin sections were obtained by
ultramicrotome (Ultracut UCT; Leica, Australia) with a diamond knife. The sections (1 mm ×
1 mm) were obtained from ischemic core area of the basal ganglia of each animal (Fig. 1),
where an infarction is consistently found in this model. The presence of ischemic injury in each
animal was ensured by occurrence of neurologic deficits. Ultrathin sections were doubly
stained with uranyl acetate and lead citrate and examined in a TEM (JEOL-1011; JEOL, Tokyo,
Japan) at 80 kV.
Measurements of the Microvascular BM–Astrocyte Contacts and of the Mean BM Density
The proportion of intact BM–astrocyte contacts and the mean electron density of the BM were
measured from five randomly selected microvessels in the ischemic basal ganglia by using
Scion Image. The circumferential length of the microvessel and the length of the intact astrocyte
endfeet that attaches to the BM were measured. The percentage of the intact contact (the length
of intact BM–astrocyte contact/total circumferential length of the microvessel × 100) was
calculated (Fig. 2). The mean density of the BM was expressed as pixel values ranging from
0 to 255. The value was normalized to that of the darkest regions of the adjacent three myelin
sheaths, because the densities of the myelin sheaths were not different among the subjects
measured (238.27 ± 15.21, P = 0.151). All measurements were performed by a researcher
blinded to the sample origins and groups.
Statistical Analysis
All of the statistical computations were performed with SAS version 8.2 (SAS Institute, Cary,
NC). The differences among all of the groups were compared by a Kruskal-Wallis test, followed
by a post hoc Dunn’s method (MMP activities and neurological deficits). The proportion of
BM–astrocyte contacts and the density of the BM and myelin sheaths were compared by a one-
way ANOVA test, followed by post hoc Duncan’s method. Differences in physiological
variables and rCBF were compared by means of a paired t-test. Correlations among the BM–
astrocyte contact, BM density, and MMP-9 activity were evaluated by using a Spearman’s test.
The values are presented as a mean ± SD. P < 0.05 was considered significant.
RESULTS
Mortality and Neurological Outcome
Two of the thirty-five rats (5.7%) that underwent MCAO died, and all four rats that underwent
the sham operation survived. After excluding five rats that did not have any neurologic deficits
after MCAO, 28 rats were finally included in this study [MCAO for 1 hr (n = 4), 4 hr (n = 5),
8 hr (n = 4), 12 hr (n = 4), 16 hr (n = 4), 20 hr (n = 4), and 48 hr (n = 3)]. The mean scores of
neurologic deficits were 8.79 ± 1.55, and the scores among the groups were not different from
one another.
No significant changes were noted in the mean arterial blood pressure, pH, PaCO2, PaO2, or
hemoglobin before or after the MCAO. The mean rCBF was decreased by about 74.4% of the
baseline 30 min after MCAO.
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Temporal Changes in the Neurovascular Unit
Microvascular BM–astrocyte contacts—In sham-operated rats, 94.08% ± 6.04% of the
microvascular surface was covered by astrocyte endfeet. At 1 hr after MCAO, the area of the
microvascular BM that was ensheathed by the astrocyte endfeet was reduced to 85.74% ±
9.45% (Fig. 3). The reduction of the intact areas of the BM–astrocyte contacts was significant
at 4 hr after MCAO (74.08% ± 7.83%, P < 0.05) and thereafter in a time-dependent manner.
At 16 hr, the loss of the BM–astrocyte contacts was marked, in that only 15.92% ± 17.54% of
the BM was attached to the astrocyte endfeet, and the contacts were rarely observed 48 hr after
MCAO.
Electron density changes in the microvascular BM—Changes in the BM were
assessed by measuring its electron density and morphology (Fig. 4). The BM appeared
homogenously dark and compact, and its margin was clean in the sham-operated rats. In
ischemic rats, the mean values of the electron corrected BM density were decreased in a time-
dependent manner. From 12 hr after MCAO, destruction of the BM was evident in that its
margin appeared fuzzy and the decrease in its density was significant (Fig. 4E). At 48 hr after
MCAO, the BM was very faint and sparse, and the mean density was decreased to 69% that
of the sham-operated rats (Fig. 4H).
Astrocytes and surrounding tissues—In the sham-operated rats, the cellular
components and adjacent matrix were undamaged and compact (Fig. 4A). Mildly swollen
astrocyte endfeet began to be seen occasionally in the ischemic core region 1 hr after MCAO
(Fig. 4B). At 8 hr, the electron micrograph depicts seriously swollen and pale astrocyte endfeet
abutting a microvessel with noticeable tissue damage (Fig. 4D). At 16 hr after MCAO, damage
to the surrounding brain tissue as well as the BM was severe. Extravasation of water caused
by the rupture of a swollen astrocytic plasma membrane and/or disruption of the BBB was
evident (Fig. 4F). Accumulated fluid was not localized to the pericapillary space but was found
to be scattered throughout the surrounding tissues at 48 hr after ischemia.
MMP Activity
MMP-9 activity was detected at 1 hr after MCAO in the ischemic hemisphere and increased
at 4 hr. The increase was significant at 12 hr after MCAO. However, MMP-2 activity was not
increased in either ischemic or nonischemic hemispheres at any time points examined until 48
hr after MCAO (Fig. 5).
Pattern of Changes in the Neurovascular Unit and MMP-9 Activity
The gross pattern of temporal changes in the loss of BM–astrocyte contacts and the decrease
of BM density appeared parallel (Fig. 3A). However, the focal loss of contacts was evident
very early after MCAO and seemed to occur before the rise of MMP-9 (Fig. 3B) or decrease
of the BM density (Fig. 3A). The loss of BM–astrocyte contacts and increase of MMP-9 seemed
to be parallel in a time-dependent manner from 4 hr to 12 hr after MCAO. Despite the fact that
the increase of MMP-9 ceased after 16 hr, the loss of contacts continued for 48 hr (Fig. 3B).
Correlation Among Loss of the BM–Astrocyte Contacts, BM Density, and MMP-9 Activity
The relationship between an increase in a matrix-degrading protease (MMP-9) and damage to
the BM (BM density and BM–astrocyte contacts) in each animal was also assessed (Fig. 6).
The intact BM–astrocyte contacts and the mean BM density showed a strong association (r =
0.784, P < 0.0001; Fig. 6A). The mean BM density and the MMP-9 activity exhibited a negative
correlation (r = −0.538, P = 0.0016; Fig. 6B). There was a strong negative correlation between
the proportion of the intact BM–astrocyte contacts and the MMP-9 activity (r = −0.711, P <
0.0001; Fig. 6C).
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DISCUSSION
Cerebral ischemia affects not only glial and neuronal cells but also microvessels. Thus, the
functional concept of the neurovascular unit, which emphasizes structural and functional
linkages among microvessels, astrocytes, and neurons, constitutes an important understanding
of the ischemic injury mechanism as well as the normal physiology of the brain (Lo et al.,
2003). Previous studies provided evidence of a loss of microvascular integrity after cerebral
ischemia in the form of a decrease in immunoreactivity to the vascular ECM molecules of the
vascular BM, loss of matrix adhesion receptors that attach the BM to astrocyte endfeet, increase
of proteinases that degrade vessel wall ECM components, and preservation of the BBB-
associated proteins by an MMP-9 gene knockout (Heo et al., 1999; Asahi et al., 2000; Fukuda
et al., 2004). The present study shows evidence of damage occurring in the BM and its adhering
contacts to astrocytes in a straightforward manner by demonstrating changes in the
ultrastructural morphology.
The electron microscopic appearance of a sparse BM and a decrease in the electron density of
the BM in this study may represent degradation and a resultant decrease of the microvascular
ECM molecules in the ischemic core. In nonhuman primates and mice, antigen losses for type
IV collagen, fibronectin, and laminin were approximately 55–75% of the control subjects after
24 hr of reperfusion following 3 hr of MCAO (Hamann et al., 1995; Vosko et al., 2003). In the
present study, the electron density of the BM was decreased to 71% at 20 hr and 69% at 48 hr
of MCAO, which was very similar to that observed in nonhuman primates and mice based on
the immunohistochemical detection of ECM molecules. The significant decrease in electron
density appeared after a longer ischemic time (12 hr of MCAO) in this study, which is consistent
with the observations in previous studies (Vosko et al., 2003). After this time point, fluid was
seen in the extracellular and extravascular space. Vasogenic edema, which is caused by
uncontrolled fluid leakage from the blood to the brain parenchyma through a damaged BBB,
contributes to an actual net volume increase of the brain (Heo et al., 2005). Brain swelling
usually reaches its maximum 2–5 days after cerebral infarction. However, the temporal patterns
of BM degradation in our study suggest that therapeutic strategies aimed at reducing brain
edema based on targeting specific molecular pathways involved in BM degradation should be
initiated as soon as possible and start before the BM suffers significant damage (at least 12 hr
after onset).
It has been postulated that degradation of the microvascular BM and BBB damage results from
an increased MMP (Asahi et al., 2001). MMP-9 is known to be maximally increased at 12–24
hr, whereas MMP-2 increases during a later time period after cerebral ischemia in rats
(Rosenberg et al., 1996; Heo et al., 2005), consistently with findings in this study. In an ex
vivo assay, microvascular ECM molecules of normal brain tissues were degraded when
supernatants from ischemic brain tissues were applied to them, which was inhibitable by MMP
inhibitors. This indicates that MMPs generated in the ischemic brain play a role in BM
degradation (Fukuda et al., 2004). The present study adds further evidence by demonstrating
that there were inverse relationships between the MMP-9 activity and both BM density and
BM–astrocyte contacts and that the degradation of the BM was strongly correlated with the
loss of BM–astrocyte contacts. These findings suggest that an increased MMP-9 activity
contributed to the degradation of ECM molecules and resultant disruption of the normal
attachment of the BM to astrocyte endfeet.
In this study, temporal changes occurring in the BM and MMP-9 activities coincided. The
increase in MMP-9, decrease in BM density, and loss of BM–astrocyte contacts paralleled each
other from 4 hr to 12 hr after MCAO. After this time, damage to the BM was more extensive,
and further loss of the contacts was seen. Most MMP-9 activities that were detected on
zymographic studies were latent forms. To degrade ECM molecules, latent MMP-9, after its
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secretion, should be activated by a proteolytic deletion of the propeptide region. The enzymatic
activity of MMPs on zymographic gels increases with longer incubation times (Kleiner and
Stetlerstevenson, 1994). Therefore, continuing degradation of the BM after a maximal increase
of MMP-9 activity in this study may be explainable.
Notably, the loss of the BM–astrocyte contacts appeared before the increase of MMP-9 or
decrease of BM density. Loss of the BM–astrocyte contacts occurred within 4 hr after ischemia,
which suggests that the loss of microvascular integrity develops very early after ischemia.
Matrix-degrading proteases other than MMPs may contribute to the loss of microvascular
integrity in cerebral ischemia. Cysteine proteases, including cathepsins B and L, are suggested
to contribute to the loss of perlecan, a component of heparan sulfate proteoglycan in the
vascular matrix. The loss of perlecan occurred 1 hr after cerebral ischemia, which was much
faster than the loss of laminin, collagen type IV, or fibronectin (Fukuda et al., 2004). In addition
to the degradation of the microvascular BM, the loss of vascular adhesion receptors that
normally glue the microvascular BM to the astrocytes may play a role in the detachment. Loss
of immunoreactivity to integrin α6β4 was observed within 1–2 hr (Wagner et al., 1997) and
that of the endothelial cell β1-integrin expression by 2 hr after MCAO in the ischemic core
(Tagaya et al., 2001). Dystroglycan, which forms a physical link between the intracellular
cytoskeleton and the vascular ECM, may be involved in early detachment (del Zoppo and
Milner, 2006). In view of the facts that the decrease of the integrins occurs very early after
ischemia and that the destruction of the BM was seen relatively late in this study, the loss of
matrix adhesion receptors may contribute to the early focal detachment of the contacts.
Alterations in the microvascular BM and its interface with astrocytes were coupled with those
in the surrounding tissues and astrocytic processes. Swelling of the astrocytes occurs within 5
min of an energy crisis (Dodson et al., 1977). The aquaporin-4, which is a water channel protein
and mediates astrocyte swelling, increased in the astrocyte endfeet 1 hr after cerebral ischemia
(Ribeiro Mde et al., 2006). Mild astrocytic swelling appeared as early as 1 hr after MCAO in
this study, which matches well the time course of aquaporin-4. After 4 hr of ischemia, severe
swelling and decreased density of the astrocytic processes were observed. Astrocytes that were
swollen and detached from the microvascular BM resulted in rupture of their membranes,
which highlights the importance of cell–ECM contact for cell survival. An extravascular
collection of fluid was first seen when the BM damage was significant and was confined around
the microvessels. However, at the time when the microvascular BM was more severely
damaged and the astrocyte endfeet were no longer visible, the extravasated fluid was scattered
throughout the brain.
The present study has shown that ultrastructural alterations occurring in the microvascular BM,
BM–astrocyte contacts, and matrix degrading MMP-9 during cerebral ischemia have close
relationships. Knowledge of the temporally coordinated pattern of the changes in cerebral
ischemia, which was investigated in this study, can elucidate the pathological processes that
occur dynamically in the neurovascular unit. This may help to initiate a protocol for the
appropriate timing of interventional therapies targeted for the protection of the microvascular
BM and astrocyte interface. However, this study was conducted in the rat model with permanent
MCAO. Although it is possible that temporal changes occurring in the BM and astrocyte
interface may be different between permanent and transient ischemic models, temporal changes
following transient MCAO were not investigated in our experiment. Therefore, this point
should be considered in interpretation of our data.
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Fig. 1.
Representative image showing the area of infarction in a model used in this experiment (2%
2,3,5-triphenyltetrazolium chloride staining). The box indicates an area in the basal ganglia
that was used for electron microscopic examinations.
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Fig. 2.
Measurement of the basement membrane and astrocyte endfeet contact. The percentage of the
intact contact is calculated as [length of intact BM–astrocyte contact (red lines)/total
circumferential length of the microvascular BM (yellow line) × 100]. A, astrocyte endfeet;
BM, basement membrane; E, nucleus of an endothelial cell; L, lumen. Original magnification
×8,000.
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Fig. 3.
The temporal pattern of changes in the basement membrane (BM)–astrocyte contacts, BM
electron densities, and MMP-9 activities at each time point after the middle cerebral artery
occlusion (MCAO). Solid lines indicate the percentage of microvascular surface attached
(A)/detached (B) to the enveloping astrocyte endfeet. The decrease is significant 4 hr after
MCAO and thereafter compared with the sham-operated group. The BM density is significantly
decreased at 12 hr and is further decreased until 48 hr. Changes in the BM–astrocyte contacts
and BM densities appear parallel. The loss of contacts and the increase of MMP-9 activities
also show a parallel pattern, particularly from 4 hr to 12 hr after MCAO. ★P < 0.05, significantly
different from the sham.
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Fig. 4.
Representative electron microscopic photographs. A: Sham control. Almost all surface areas
of the microvessel are covered by astrocyte endfeet. B: One hour after middle cerebral artery
occlusion (MCAO). C: Four hours after MCAO. Swelling of the astrocytes and focal
detachment of the astrocyte endfeet from the basement membrane (BM) are seen. D: Eight
hours after MCAO. A marked astrocyte swelling and a further decrease in the intact portion
of the contacts are demonstrated. E: Twelve hours after MCAO. The proportion of the intact
BM–astrocyte contacts is markedly decreased, and the BM is damaged. F: Sixteen hours after
MCAO. Further degradation of the BM and ruptured astrocytes is evident. G: Twenty hours
after MCAO. There is excessive accumulation of water around the microvessels. H: Forty-
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eight hours after MCAO. The astrocyte endfeet are no longer visible, and the BM is very faint.
Arrowheads in the inset (magnified view) indicate the BM. Original magnification ×8,000.
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Fig. 5.
A: Representative zymograms showing clear bands of MMP-2 and MMP-9. B: There is no
change in MMP-2 activities. C: MMP-9 activity is significantly increased at 12, 16, and 20 hr
after middle cerebral artery occlusion (★P < 0.05). NI, nonischemic hemisphere; I, ischemic
hemisphere; Std, mixture of recombinant MMP-2 and MMP-9 used as the standard.
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Fig. 6.
Correlations among percentages of the basement membrane (BM)–astrocyte contacts, mean
electron densities of the BM, and MMP-9 activities. A: BM–astrocyte contacts and mean BM
densities show a positive correlation (r = 0.784, P < 0.001). B: BM densities and MMP-9
activities show a negative correlation (r = −0.538, P 5 0.0016). C: BM–astrocyte contacts and
MMP-9 activities show a negative correlation (r = −0.711, P < 0.001).
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